weight-body
Medical Weight Loss: What It Is and Who It's For
Last reviewed: May 2026 · Haute MD Editorial Team
Medical weight loss is a physician-supervised approach to fat reduction that goes beyond diet and exercise advice — incorporating metabolic evaluation (thyroid, insulin resistance, hormone levels), behavioral counseling, and when appropriate, FDA-approved prescription medications (GLP-1 agonists like semaglutide/Ozempic, phentermine, topiramate combinations). It is most appropriate for patients with a BMI of 30+ or 27+ with weight-related health conditions (type 2 diabetes, hypertension, sleep apnea, metabolic syndrome). Medical weight loss produces significantly better outcomes than self-directed programs for patients with metabolic obesity.
How medical weight loss differs from diet programs
Diet programs address caloric intake and behavior. Medical weight loss addresses the underlying biology of weight regulation — hormonal drivers of hunger and satiety, metabolic rate, insulin sensitivity, and genetic predisposition. GLP-1 medications like semaglutide (Ozempic/Wegovy) work by mimicking gut hormones that signal satiety to the brain and slow gastric emptying — reducing appetite and food intake without willpower. This addresses the biological, not just behavioral, drivers of obesity.
What to expect from a medical weight loss evaluation
A comprehensive metabolic evaluation includes: thyroid function (hypothyroidism is a correctable cause of weight gain and resistance to loss), fasting glucose and insulin (insulin resistance affects 50%+ of overweight adults), lipid panel, sex hormones, cortisol (if Cushing's syndrome is suspected), and body composition analysis. Treatment is then individualized — not every patient needs medication; some respond to metabolic correction alone.
The role of GLP-1 medications
GLP-1 receptor agonists (semaglutide/Ozempic/Wegovy, tirzepatide/Mounjaro/Zepbound, liraglutide/Saxenda) are the most significant advance in obesity medicine in decades. In clinical trials, semaglutide 2.4mg produces 15-17% body weight loss on average — more than any previous non-surgical medication. They are most effective when combined with dietary modification and are typically covered by insurance when prescribed for diabetes; coverage for obesity is variable.
Frequently Asked Questions
Is medical weight loss the same as bariatric surgery?
No. Medical weight loss uses non-surgical interventions (medication, lifestyle, metabolic management). Bariatric surgery (gastric bypass, sleeve gastrectomy) is surgical reduction of stomach size and produces greater weight loss but carries surgical risk. GLP-1 medications have narrowed the gap — producing 15-20% weight loss comparable to some older bariatric procedures.
Can I get medical weight loss treatment from my primary care doctor?
Yes. Primary care physicians can prescribe GLP-1 medications and conduct metabolic evaluations. Endocrinologists and obesity medicine specialists offer more comprehensive metabolic evaluation and management. Many medical weight loss programs are offered through specialized clinics or telehealth platforms.
Will I regain weight when I stop GLP-1 medication?
Weight regain is common after stopping GLP-1 medications — typically 50-70% of lost weight returns within one year of discontinuation. This is because obesity is a chronic condition driven by biology, not simply a behavior problem. Long-term or indefinite medication use is often required to maintain results, similar to blood pressure or cholesterol medications.
What is the difference between Ozempic and Wegovy?
Both contain semaglutide (the same molecule) but at different doses. Ozempic (0.5-2mg weekly) is FDA-approved for type 2 diabetes. Wegovy (2.4mg weekly) is FDA-approved for chronic weight management at a higher dose producing greater weight loss. They are interchangeable at appropriate doses but have different approvals and insurance coverage.
Get Help Now
Speak with a Haute MD Internal Medicine physician
Dr. Alexander Golberg
Internal Medicine · New York, NY
View Profile
Dr. Kern Brar
MD
Internal Medicine · Oceanside, CA
View ProfileAre you a Internal Medicine physician?
Join Haute MD Network and have your profile featured alongside these answers.
Apply for the NetworkRelated Guides
Guide · WEIGHT-BODY
What Is GLP-1 Therapy? Ozempic, Wegovy, and Mounjaro Explained
GLP-1 receptor agonists like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) produce 15-22% body weight loss. Learn how they work and who qualifies.
Read GuideGuide · WEIGHT-BODY
Body Contouring: Non-Surgical vs. Surgical Options Explained
Body contouring removes stubborn fat and tightens skin through surgical (liposuction, tummy tuck) or non-surgical (CoolSculpting, Emsculpt) methods. Learn which is right for you.
Read GuideGuide · WEIGHT-BODY
Insulin Resistance and Weight Gain: What's the Connection?
Insulin resistance makes weight loss harder and drives fat storage — especially around the abdomen. Learn how to identify it and what to do about it.
Read Guide